MediBIC, Kazusa DNA Research Institute to Collaborate in New Drug Development.Tokyo, Japan, Sept 12, 2005 - (JCNN JCNN Japan Corporate News Network ) - MediBIC announced on September 12 that it has signed an agreement with the Kazusa DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. Research Institute (KDRI KDRI Kazusa DNA Research Institute (Japan) ) on new drug development. Under the terms of the agreement, the two companies will collaborate in molecular analysis and searches for candidate compounds using KDRI's expertise. Specifically, MediBIC has launched a project for developing agents using KDRI's achievements in gene research of mammals. MediBIC will retain the right to sell final deliverables of the project. The Kazusa DNA Research Institute is one of the world's leading research institutions specializing in gene studies of mammals and plants. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion